Article
Cyclin E as a Coactivator of the Androgen Receptor
21 Aug 2000
Abstract excerpt
Androgens play an important role in the growth of prostate cancer, but the molecular mechanism that underlies development of resistance to antiandrogen therapy remains unknown. Cyclin E has now been shown to increase the transactivation activity of the human androgen receptor (AR) in the presence of its ligand dihydrotestosterone. The enhancement of AR activity by cyclin E was resistant to inhibition by the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
